Ordinary Adjustment | Solactive China Biotech Index | July 2021
In the ordinary rebalance the following composition will be implemented effective open 12.07.2021:
JIANGSU HENGRUI MEDICINE CO LTD CLASS A |
WUXI APPTEC CO LTD-A |
WUXI BIOLOGICS CAYMAN INC |
BEIGENE LTD-ADR |
HANSOH PHARMACEUTICAL GROUP CO |
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO LTD |
CANSINO BIOLOGICS INC |
SINO BIOPHARMACEUTICAL LTD ORD |
SHENZHEN KANGTAI BIOLOGICA-A |
INNOVENT BIOLOGICS INC |
ZAI LAB LTD |
WALVAX BIOTECHNOLOGY CO-A |
SHANGHAI JUNSHI BIOSCIENCES CO LTD |
HUALAN BIOLOGICAL ENGINEER-A |
BGI GENOMICS CO LTD-A |
GENSCRIPT BIOTECH CORP |
SHANGHAI RAAS BLOOD PRODUC-A |
BETTA PHARMACEUTICALS CO L-A |
REMEGEN CO LTD-H |
BEIJING TIANTAN BIOLOGICAL-A |
Hygeia Healthcare Holdings Co Ltd |
CHINA MEDICAL SYSTEM HOLDINGS LTD |
LIVZON PHARMACEUTICAL GROU-A |
NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO LTD |
ZHEJIANG WOLWO BIO-PHARMAC-A |
DAAN GENE CO LTD-A |
PHARMABLOCK SCIENCES NANJI-A |
HUTCHISON CHINA MEDITECH-ADR |
ANHUI ANKE BIOTECHNOLOGY G-A |
CHINA NATIONAL MEDICINES-A |